Skip to main content
. 2013 Jan 9;31(1):38–44. doi: 10.1111/1755-5922.12008

Figure 2.

Figure 2

Cambridge pulmonary hypertension outcome review (CAMPHOR) and treatment satisfaction questionnaire for medicine (TSQM). (A) Mean (±SE) CAMPHOR scores presented for baseline (iloprost; n = 72), week 6 (inhaled treprostinil; n = 67), week 12 (inhaled treprostinil; n = 67), and month 12 (inhaled treprostinil; n = 24). aP < 0.001; bP < 0.05; nsnot significant. (B) The mean (±SE) TSQM score for each category is presented for baseline (iloprost; n = 72) and week 12 (inhaled treprostinil; n = 66). aP < 0.001.